BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 8, 2019
View Archived Issues
DKK2 unveiled as a potential therapeutic target for lung cancer
Read More
Where TH2 cells go, blood vessels are built
Read More
New metabolic syndrome target
Read More
Wild moms are good for offspring microbiome
Read More
First-in-human data presented for GSK-3036656
Read More
Recruitment ongoing in first in human trial of NOV-1601
Read More
JZP-458 to enter phase II/III development
Read More
Cleave Therapeutics obtains financing to advance its VCP/p97 inhibitor
Read More
BDGR-4 shows prophylactic and treatment potential for encephalitic alphaviruses
Read More
Cue Biopharma begins phase I study of CUE-101
Read More
Phase III data announced for setmelanotide in POMC and LEPR deficiency obesities
Read More
Phase I/II study of ASTX-295 recruiting participants
Read More
Serum visfatin as a diagnostic marker of patients with AMI
Read More
Apoptosis regulator Bcl-2 inhibitors patented by Zeno Royalties & Milestones
Read More
Changsha Hooz Bioscience & Technology compounds target UHRF1 and/or HDAC1
Read More
PI4KIII-beta inhibitors discovered at GlaxoSmithKline
Read More
Idorsia Pharmaceuticals describes C5aR antagonists
Read More
Favorable safety and PK data from phase Ib/IIa study of recombinant human plasma gelsolin
Read More
FDA grants approval to initiate phase Ib/II stud of L-DOS-47 plus doxorubicin in pancreatic cancer
Read More
Cancer Research UK and Hummingbird Bioscience to partner to advance HMBD-001
Read More
Servier enrolling subjects in first-in-human trial of S-65487
Read More
Chiesi Farmaceutici initiates phase I study of CHF-6523 in COPD
Read More
Novel T-cell subtype predicts risk of anaphylactic shock
Read More
Applied Therapeutics reports data from SAD portion of phase I/II study of AT-007
Read More